Metagenomi (MGX) announced that Eric Bjerkholt, CFO of Mirum Pharmaceuticals (MIRM), will join Metagenomi’s Board of Directors, serving on Metagenomi’s Audit and Compensation committees, effective January 27, 2025.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGX:
- Metagenomi price target raised to $14 from $7 at H.C. Wainwright
- Metagenomi presents updated preclinical NHP data at ASH meeting
- Metagenomi presents updated preclinical data in Hemophilia A at ASH
- Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
- Class Action Lawsuit Against Metagenomi Inc. (NASDAQ:MGX)